Surefire snags $16.4M; Cigna stands firm on Dx mandate;

@FierceMedDev: At AdvaMed, European regulations are on many CEOs' minds. Editor's corner | Follow @FierceMedDev

@MarkHFierce: The debt ceiling/budget fight has given an opening to device tax opponents. They hope for a repeal before year-end. More | Follow @MarkHFierce

@MichaelGFierce: Alnylam heralds positive results for RNAi amyloidosis drug. Story | Follow @MichaelGFierce

> Colorado's Surefire Medical has raised $16.4 million to market catheters designed to deliver cancer treatments. Article

> A Cigna executive said the insurer will expand a new policy requiring genetic counseling before it will cover certain diagnostic tests. Story

> Fresh off its FDA approval, NeoTract has treated its first patient with the UroLift device for enlarged prostates. News

> Luminex ($LMNX) won FDA clearance and a CE mark for its xTAG CYP2C19 diagnostic kit. Release

> In a new study, Respicardia's implantable sleep apnea device decreased patients' apnea-hypopnea index by more than 50% and improved oxygenation at about the same rate. More

> Medtronic ($MDT) has forked over $290,000 to settle a lawsuit claiming it paid Hispanic employees less than their white colleagues. Item

Biotech News

@FierceBiotech: The 2013 Fierce 15 biotech execs take a bow. Editor's corner | Follow @FierceBiotech

@JohnCFierce: Some folks might want to adjust their timelines on ARN-509. PhIII is coming. Item | Follow @JohnCFierce

@DamianFierce: Thanks to everyone cheering my trip to FierceBiotech! | Follow @DamianFierce

> SEC charges another biotech profiteer linked to insider trading scheme. More

> Ex-InterMune CEO's press-release pomp could leave legal legacy. Story

> AbbVie continues deal spree with $405M CF tie-up with Galapagos. News

Pharma News

@FiercePharma: Top story on our website this A.M.: Who are the richest biopharma execs? Not all the usual suspects. Article | Follow @FiercePharma

> GlaxoSmithKline's China sales set for 30% hit, analysts figure. More

> Servier offers $483M to buy out other Egis shareholders. Story

> Pfizer rolls out digital reps in U.K., hoping for access to primary-care docs. Article

Pharma Manufacturing News

@EricPFierce: After sales of Bydureon came up short, Bristol-Myers, AstraZeneca report manufacturing has too. Article | Follow @EricPFierce

> FDA warns Agila plant over torn gloves. Story

> Pharma squares off against compounders in lobbying fight. News

> J&J wins a bright spot after string of recalls. More

> FDA beefs up Indian staff in face of serious problems. Story

> U.K., Australia gather FDA intel on Ranbaxy ban. Report

Biotech Research News

@EmilyMFierce: $3.7M NIH program to fund biomedical research training. Item | Follow @EmilyMFierce

> Stem cell therapy protects vision in preclinical retinal disease study. More

> Pre-leukemia drug shows brain tumor regression in mice. News

> Stem cell reprogramming made easier by removing one protein. Report

> New compound kills tuberculosis bacterium in lab tests. Story

> NIH launches $45M Alzheimer's research effort, awards funds to 3 preclinical studies. Article

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.